Inflammation, CRP and Cardiovascular Risk: Is it Time to Change Framiningham Risk Score? |
|
|---|---|
|
|
|
| Launch in standalone player | |
| Air date: | Wednesday, November 02, 2005, 3:00:00 PM |
| Category: | Wednesday Afternoon Lectures |
| Description: | While lipids play a crucial role in myocardial infarction, half of all cardiovascular events occur among individuals with normal lipid levels.
Fortunately, in addition to being a disorder of lipids, atherothrombosis is now widely understood to be an inflammatory disease and several biomarkers of inflammation have proven effective in identifying individuals at high risk for future vascular events. Clinically, the most important of these biomarkers is C-reactive protein (CRP), a pentraxin pattern recognition molecule of innate immunity that is commonly measured as an adjunct to global risk prediction.
For more information, visit http://www.researchmatters.harvard.edu/people.php?people_id=268 The NIH Director's Wednesday Afternoon Lecture Series includes weekly scientific talks by some of the top researchers in the biomedical sciences worldwide. |
| Author: | Paul M Ridker, M.D., M.P.H. Harvard Medical School |
| Runtime: | 75 minutes |
| Download: | Download
Video How to download a Videocast |
| CIT File ID: | 12873 |
| CIT Live ID: | 4250 |
| Permanent link: | http://videocast.nih.gov/launch.asp?12873 |